|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
- Name 5-Fluorouracil
- EINECS200-085-6
- CAS No. 51-21-8
- Density1.53 g/cm3
- PSA65.72000
- LogP-0.79770
- Solubilityinsoluble in water
- Hazard Symbols
Xn,
T,
C,
Xi- Synonyms
Xn,T,C,Xi- Article Data130
5-Fluorouracil Synthetic route
- 56311-36-5, 100814-55-9, 100814-58-2
trans-5-fluoro-6-acetoxy-5,6-dihydrouracil
- 51-21-8
5-fluorouracil
Conditions
Conditions Yield With triethylamine at 60℃; 100% - 65906-75-4, 76481-58-8, 81033-59-2, 84471-52-3, 84471-53-4
(+/-)-t-6-butoxy-r-5-ethoxycarbonyl-5-fluoro-5,6-dihydrouracil
- 51-21-8
5-fluorouracil
ConditionsConditions Yield With hydrogenchloride for 1h; Product distribution; Heating; variation of reagent, temperature; in ethanol; 95% - 65905-96-6
methyl 5-fluoro-4-methoxy-2,6-dioxohexahydro-5-pyrimidinecarboxylate
- 51-21-8
5-fluorouracil
ConditionsConditions Yield With hydrogenchloride In water for 2.5h; 95% - 99429-06-8
2,5-difluoro-4-chloro-pyrimidine
- 51-21-8
5-fluorouracil
ConditionsConditions Yield With sodium hydroxide In water at 80℃; for 4h; 93% - 51-21-8
5-fluorouracil
ConditionsConditions Yield With sulfuric acid In water at 80℃; for 7h; 93% - 13593-36-7
5-fluoro-6-chlorouracil
- 51-21-8
5-fluorouracil
ConditionsConditions Yield With acetic acid; zinc at 100℃; for 5h; var.: reag.: hydrogen, Et3N or NaOH, cat.: Pd/C, in EtOH, RT; 91% ConditionsConditions Yield With C19XeF6 In dichloromethane for 24h; Ambient temperature; 90% With fluorine; trifluoroacetic acid at -10℃; under 2250.23 Torr; Reagent/catalyst; Temperature; Pressure; Inert atmosphere; 89.4% 81.4% ConditionsConditions Yield With fluoroacetamide; lithium diisopropyl amide In diethyl ether at 0℃; for 4h; 88% With fluoroacetamide; lithium diisopropyl amide In diethyl ether at 0℃; for 4h; a novel ring transformation reaction; 88% ConditionsConditions Yield In water 87.7% A
- 51-21-8
5-fluorouracil
B
- 220141-70-8
5-fluoroorotic acid hydrate
ConditionsConditions Yield In trichloromonofluoromethane (CFCl3); water; trifluoroacetic acid; Polytetrafluoroethylene A n/a
B 86%5-Fluorouracil Chemical Properties
Molecular structure of Fluorouracil (CAS NO.51-21-8) is:
Product Name: Fluorouracil
CAS Registry Number: 51-21-8
IUPAC Name: 5-fluoro-1H-pyrimidine-2,4-dione
Molecular Weight: 130.077223 [g/mol]
Molecular Formula: C4H3FN2O2
XLogP3: -0.9
H-Bond Donor: 2
H-Bond Acceptor: 3
EINECS: 200-085-6
Melting Point: 282-286 °C (dec.)(lit.)
Surface Tension: 46.1 dyne/cm
Density: 1.53 g/cm3
Flash Point: 196.5 °C
Enthalpy of Vaporization: 67.78 kJ/mol
Boiling Point: 401.4 °C at 760 mmHg
Vapour Pressure: 5.13E-07 mmHg at 25°C
Water Solubility: 12.2 g/L 20 °C
Sensitive: Air Sensitive
Stability: Stable. Light sensitive. Combustible. Incompatible with strong oxidizing agents, strong bases.
Product Categories: Pharmaceutical Raw Materials;PYRIMIDINE;Heterocycles;Pyridines, Pyrimidines, Purines and Pteredines;Phenylacetic acid;Tegafur Carmofur;Nucleotides and Nucleosides;Biochemistry;Chemical Reagents for Pharmacology Research;Nucleobases and their analogs;Nucleosides, Nucleotides & Related Reagents;Nucleic acids;Bases & Related Reagents;Nucleotides;API's;Antitumour5-Fluorouracil History
Fluorouracil (CAS NO.51-21-8) was synthesized by Robert Duschinsky in the late 1950s.
5-Fluorouracil Uses
Fluorouracil (CAS NO.51-21-8) can be used in against cancer for about 40 years, acts in several ways, but principally as a thymidylate synthase inhibitor. It can be used in colorectal cancer and pancreatic cancer,also it can be used for treating actinic (solar) keratoses and some types of basal cell carcinomas of the skin.
5-Fluorouracil Toxicity Data With Reference
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source dog LD50 oral 30mg/kg (30mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING Oyo Yakuri. Pharmacometrics. Vol. 16, Pg. 303, 1978. guinea pig LD50 intravenous 25mg/kg (25mg/kg) VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION Japanese Journal of Pharmacology. Vol. 30, Pg. 871, 1980. hamster LD10 parenteral 140mg/kg (140mg/kg) Journal of Surgical Oncology. Vol. 15, Pg. 355, 1980. human TDLo intravenous 6mg/kg/3D (6mg/kg) CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE
CARDIAC: OTHER CHANGES
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGESBritish Medical Journal. Vol. 1, Pg. 547, 1978. human TDLo oral 450mg/kg/30D (450mg/kg) GASTROINTESTINAL: OTHER CHANGES
BLOOD: CHANGES IN BONE MARROW NOT INCLUDED ABOVECancer Vol. 39, Pg. 1936, 1977. man TDLo intravenous 39mg/kg/1D-I (39mg/kg) CARDIAC: CHANGES IN CORONARY ARTERIES American Heart Journal. Vol. 114, Pg. 433, 1987. man TDLo intravenous 122mg/kg/9W-I (122mg/kg) SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" Australian and New Zealand Journal of Medicine. Vol. 22, Pg. 385, 1992. mouse LD50 intracrebral 41600ug/kg (41.6mg/kg) PERIPHERAL NERVE AND SENSATION: SENSORY CHANGE INVOLVING PERIPHERAL NERVE
SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
SENSE ORGANS AND SPECIAL SENSES: OTHER: EYEChemotherapy Vol. 15, Pg. 519, 1967. mouse LD50 intraperitoneal 100mg/kg (100mg/kg) Eksperimental'naya i Klinicheskaya Farmakoterapiya. Vol. 7, Pg. 100, 1977. mouse LD50 intravenous 81mg/kg (81mg/kg) Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 4, Pg. 90, 1973. mouse LD50 oral 115mg/kg (115mg/kg) Journal of Medicinal Chemistry. Vol. 21, Pg. 738, 1978. mouse LD50 subcutaneous 169mg/kg (169mg/kg) Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 4, Pg. 90, 1973. mouse LD50 unreported 171mg/kg (171mg/kg) Cancer Research. Vol. 46, Pg. 2703, 1986. mouse LDLo intratracheal 200mg/kg (200mg/kg) Toxicology Letters. Vol. 30, Pg. 63, 1986. rabbit LD50 oral 18900ug/kg (18.9mg/kg) BEHAVIORAL: MUSCLE WEAKNESS
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 2603, 1974. rabbit LDLo intravenous 15mg/kg (15mg/kg) VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION Japanese Journal of Pharmacology. Vol. 30, Pg. 871, 1980. rat LD50 intramuscular 240mg/kg (240mg/kg) K'at'ollik Taehak Uihakpu Nonmunjip. Journal of Catholic Medical College. Vol. 38, Pg. 481, 1985. rat LD50 intraperitoneal 70mg/kg (70mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
GASTROINTESTINAL: NAUSEA OR VOMITINGOyo Yakuri. Pharmacometrics. Vol. 5, Pg. 569, 1971. rat LD50 intravenous 245mg/kg (245mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
GASTROINTESTINAL: NAUSEA OR VOMITINGOyo Yakuri. Pharmacometrics. Vol. 5, Pg. 569, 1971. rat LD50 oral 230mg/kg (230mg/kg) Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 4, Pg. 90, 1973. rat LD50 parenteral 500mg/kg (500mg/kg) Recent Results in Cancer Research. Vol. 52, Pg. 76, 1975. rat LD50 rectal 884mg/kg (884mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
GASTROINTESTINAL: OTHER CHANGESKiso to Rinsho. Clinical Report. Vol. 12, Pg. 1309, 1978. rat LD50 subcutaneous 217mg/kg (217mg/kg) Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 4, Pg. 90, 1973. women TDLo intravenous 27mg/kg/4D-C (27mg/kg) CARDIAC: OTHER CHANGES British Medical Journal. Vol. 294, Pg. 125, 1987. women TDLo intravenous 150mg/kg/17W- (150mg/kg) BLOOD: OTHER HEMOLYSIS WITH OR WITHOUT ANEMIA British Journal of Haematology. Vol. 65, Pg. 357, 1987. 5-Fluorouracil Safety Profile
Hazard Codes:
Xn,Xi ;
T;
C
Risk Statements: 20/21/22
R20/21/22: Harmful by inhalation, in contact with skin and if swallowed.
Safety Statements: 36/37/39-22
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection.
S22: Do not breathe dust.
RIDADR: UN 2811 6.1/PG 3
WGK Germany: 3
RTECS: YR0350000
F: 10-23
Hazard Note: Irritant/Highly Toxic
TSCA: T
HazardClass: 6.1
PackingGroup: III
HS Code: 293359955-Fluorouracil Specification
Fluorouracil , its cas register number is 51-21-8. It also can be called 2,4(1H,3H)-Pyrimidinedione, 5-fluoro- ; 2,4-Dioxo-5-fluoropyrimidine ; 5-FU ; 5-Faracil ; 5-Fluor-2,4(1H,3H)-pyrimidindion ; 5-Fluor-2,4-dihydroxypyrimidin .It is a white to nearly white crystalline powder and insoluble in water.
Post a RFQ1
What can I do for you?
Get Best PriceGet Best Price for 51-21-8 5-Fluorouracil
Related Products- 512180-63-12-(4-(tert-Butoxycarbonylamino)-2-nitrophenyl)acetic acid
- 51218-45-2Acetamide,2-chloro-N-(2-ethyl-6-methylphenyl)-N-(2-methoxy-1-methylethyl)-
- 51218-49-6Acetamide,2-chloro-N-(2,6-diethylphenyl)-N-(2-propoxyethyl)-
- 51218-95-2Benzenamine, 2-ethyl-N-(2-methoxyethyl)-6-methyl-
- 51219-18-211-Oxa-2,4,9-triazatridecanoicacid, 8-carboxy-3-imino-12,12-dimethyl-10-oxo-, 1-(phenylmethyl) ester, (8S)-
- 51219-19-311-Oxa-2,4,9-triazatridecanoicacid, 8-carboxy-3-imino-12,12-dimethyl-10-oxo-4-[(phenylmethoxy)carbonyl]-,1,3-bis(phenylmethyl) ester, (8S)-
- 51219-87-52,2-Propanediol-d2,1,1,1,3,3,3-hexafluoro- (9CI)
- 51219-89-7Urea, tetra(methyl-d3)-(9CI)
- 51220-84-9Leucine,N-[(4-methylphenyl)sulfonyl]-, methyl ester
- 5122-16-7Ethanone,2-bromo-1-(2,3,4,5,6-pentafluorophenyl)-
Hot Products
- 53-43-0Dehydroepiandrosterone
- 85622-93-1Temozolomide
- 1119-34-2L-ARGININE HCL
- 341031-54-7Sunitinib malate
- 2809-21-41-Hydroxyethane-1,1-diphosphonic Acid
- 5471-51-2Raspberry ketone
- 10124-56-8Sodium metaphosphate
- 50-02-2Dexamethasone
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- About us - Payment - Contact us - Links - Help Center - Disclaimer
- SiteMap | Manufacturers | VIP Product | Suppliers | CAS | New CAS | Cas Database | Article Data | Chemical Catalog | Product Name
- ©2008 LookChem.com,License:ICP NO.:Zhejiang16009103 complaints:service@lookchem.com
- [Hangzhou]86-571-87562588,87562578,87562573 Our Legal adviser: Lawyer
- Hazard Symbols
